These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-term effects of etretinate on the liver in psoriasis. Camuto P; Shupack J; Orbuch P; Tobias H; Sidhu G; Feiner H Am J Surg Pathol; 1987 Jan; 11(1):30-7. PubMed ID: 3789256 [TBL] [Abstract][Full Text] [Related]
5. Differential hepatotoxicity of two oral retinoids (etretinate and isotretinoin) in a patient with palmoplantar psoriasis. Vahlquist A; Lööf L; Nordlinder H; Rollman O; Vahlquist C Acta Derm Venereol; 1985; 65(4):359-62. PubMed ID: 2413699 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and therapeutic efficacy of retinoids in skin diseases. Larsen FG; Nielsen-Kudsk F; Jakobsen P; Weismann K; Kragballe K Clin Pharmacokinet; 1992 Jul; 23(1):42-61. PubMed ID: 1617858 [TBL] [Abstract][Full Text] [Related]
7. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids]. Gollnick H; Orfanos CE Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105 [TBL] [Abstract][Full Text] [Related]
8. A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis. Glazer SD; Roenigk HH; Yokoo H; Sparberg M J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):683-7. PubMed ID: 7068976 [TBL] [Abstract][Full Text] [Related]